Continuation with statin therapy and the risk of primary cancer: A population-based study

Preventing Chronic Disease

Volumn 9, Issue 8, 2012, Pages

  Lutski, Miriam ^a   Shalev, Varda ^a,b   Porath, Avi ^b   Chodick, Gabriel ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b MACCABI HEALTHCARE SERVICES   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HUMAN; ISRAEL; LONG TERM CARE; MALE; MIDDLE AGED; NEOPLASM; PATIENT CARE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SOCIOECONOMICS;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; COHORT STUDIES; CONTINUITY OF PATIENT CARE; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISRAEL; LONG-TERM CARE; MALE; MIDDLE AGED; NEOPLASMS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SOCIOECONOMIC FACTORS;

EID: 84869049184     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: 10.5888/pcd9.120005     Document Type: Article

References (31)

1. American Cancer Society. Cancer facts and figures 2010. American Cancer Society, 2010. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-and-figures-2010. Accessed May 4, 2012.
2. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis 2010;31(1):100-10
3. Israel Center for Disease Control. Health status in Israel 2010. Tel-Hashomer (ISR): Israel Ministry of Health; 2010.
4. Duncan RE, El-Sohemy A, Archer MC. Statins and cancer development. Cancer Epidemiol Biomarkers Prev 2005;14(8):1897-8
5. Bonovas S, Filioussi K, Tsavaris N, Sitaras NM. Statins and cancer risk: a literature-based meta-analysis and meta -regression analysis of 35 randomized controlled trials. J Clin Oncol 2006;24(30):4808-17
6. Das D, Arber N, Jankowski JA. Chemoprevention of colorectal cancer. Digestion 2007;76(1):51-67
7. Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clin Cancer Res 2003;7. 9(1):10-9
8. Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, et al. Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst 2006;98(10):700-7.
9. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, et al. Statins and the risk of colorectal cancer. N Engl J Med 2005;352(21):2184-92.
10. Vinogradova Y, Coupland C, Hippisley-Cox J. Exposure to statins and risk of common cancers: a series of nested case-control studies. BMC Cancer 2011;11:409.
11. Beiderbeck AB, Holly EA, Sturkenboom MC, Coebergh JW, Stricker BH, Leufkens HG. Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma. Am J Epidemiol 2003;157(6):510-6
12. Fortuny J, de Sanjose S, Becker N, Maynadié M, Cocco PL, Staines A, et al. Statin use and risk of lymphoid neoplasms: results from the European Case-Control Study EPILYMPH. Cancer Epidemiol Biomarkers Prev 2006;15(5):921-5
13. Coogan PF, Rosenberg L, Strom BL. Statin use and the risk of 10 cancers. Epidemiology 2007;18(2):213-9.
14. Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD. Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med 2009;169(3):260-8.
15. Chodick G, Amital H, Shalem Y, Kokia E, Heymann AD, Porath A, et al. Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study. PLoS Med 2010;7(9):e1000336
16. Valuck RJ, Williams SA, MacArthur M, Saseen JJ, Nair KV, McCollum M, et al. A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization. Clin Ther 2003;25(11):2936-57.
17. [1995] Census of population and housing. Jerusalem (ISR): Israel Central Bureau of Statistics; 1998.
18. Cox D. Regression models and life-tables. J R Stat Soc Series B Stat Methodol 1972;34(2):187-202.
19. Blais L, Desgagne A, LeLorier J. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 2000;160(15):2363-8.
20. Friis S, Poulsen AH, Johnsen SP, McLaughlin JK, Fryzek JP, Dalton SO, et al. Cancer risk among statin users: a population-based cohort study. Int J Cancer 2005;114(4):643-7.
21. Bonovas S, Filioussi K, Tsantes A, Sitaras NM. Use of statins and risk of haematological malignancies: a metaanalysis of six randomized clinical trials and eight observational studies. Br J Clin Pharmacol 2007;64(3):255-62.
22. Jacobs EJ, Newton CC, Thun MJ, Gapstur SM. Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort. Cancer Res 2011;71(5):1763-71.
23. Sassano A, Lo Iacono M, Antico G, Jordan A, Uddin S, Calogero RA, et al. Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins. Mol Cancer Ther 2009;8(3):615-25.
24. Yang YC, Huang WF, Chuan LM, Xiao DW, Zeng YL, Zhou DA, et al. In vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cells. Chemotherapy 2008;54(6):438-46.
25. Friedman GD, Flick ED, Udaltsova N, Chan J, Quesenberry CP Jr, Habel LA. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf 2008;17(1):27-36.
26. Zhang Y, Holford TR, Leaderer B, Zahm SH, Boyle P, Morton LM, et al. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 2004;15 (4):419-28.
27. Abughosh SM, Kogut S, Andrade S, Larrat P, Gurwitz J. Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients. J Manag Care Pharm 2004;10(5):404-11.
28. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007;16 (3):241-9.
29. Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, et al. Statin adherence and risk of accidents: a cautionary tale. Circulation 2009;119(15):2051-7.
30. Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM. Statin use and risk of breast cancer. Cancer 2008;112(1):27-33.
31. Boudreau DM, Yu O, Buist D, Miglioretti D. Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control 2008;19(7):767-74.